These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8721890)
1. Risk factors for clozapine discontinuation among 805 patients in the VA hospital system. Moeller FG; Chen YW; Steinberg JL; Petty F; Ripper GW; Shah N; Garver DL Ann Clin Psychiatry; 1995 Dec; 7(4):167-73. PubMed ID: 8721890 [TBL] [Abstract][Full Text] [Related]
2. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Ucok A; Yağcıoğlu EA; Yıldız M; Kaymak SU; Saka MC; Taşdelen R; Danacı AE; Şenol ŞH Psychiatry Res; 2019 May; 275():149-154. PubMed ID: 30908979 [TBL] [Abstract][Full Text] [Related]
3. Predictors of clozapine discontinuation in patients with schizophrenia. Krivoy A; Malka L; Fischel T; Weizman A; Valevski A Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905 [TBL] [Abstract][Full Text] [Related]
4. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215 [TBL] [Abstract][Full Text] [Related]
5. Impact of clozapine on completed suicide. Sernyak MJ; Desai R; Stolar M; Rosenheck R Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902 [TBL] [Abstract][Full Text] [Related]
6. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179 [TBL] [Abstract][Full Text] [Related]
7. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249 [TBL] [Abstract][Full Text] [Related]
8. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey. Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824 [TBL] [Abstract][Full Text] [Related]
9. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758 [TBL] [Abstract][Full Text] [Related]
10. Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. Kelly DL; Dixon LB; Kreyenbuhl JA; Medoff D; Lehman AF; Love RC; Brown CH; Conley RR J Clin Psychiatry; 2006 Sep; 67(9):1404-11. PubMed ID: 17017827 [TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates. Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906 [TBL] [Abstract][Full Text] [Related]
12. Substance abuse and clozapine treatment. Buckley P; Thompson PA; Way L; Meltzer HY J Clin Psychiatry; 1994 Sep; 55 Suppl B():114-6. PubMed ID: 7961553 [TBL] [Abstract][Full Text] [Related]
13. The effects of clozapine on aggression and substance abuse in schizophrenic patients. Volavka J J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients. Davis MC; Fuller MA; Strauss ME; Konicki PE; Jaskiw GE Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466 [TBL] [Abstract][Full Text] [Related]
15. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system. Reid WH; Mason M J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670 [TBL] [Abstract][Full Text] [Related]
16. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study. Miodownik C; Lerner V; Kibari A; Toder D; Cohen H J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia. Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815 [TBL] [Abstract][Full Text] [Related]
18. Professional perception of clozapine use in patients with dual psychosis. Grau-López L; Szerman N; Torrens M; Basurte I; Vega P; Martínez-Raga J; Casas M; Roncero C Actas Esp Psiquiatr; 2020 May; 48(3):99-105. PubMed ID: 32905602 [TBL] [Abstract][Full Text] [Related]
19. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial. Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436 [TBL] [Abstract][Full Text] [Related]
20. Clozapine as a first treatment for schizophrenia. Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]